Notice2023-25063

Notice of Intent To Grant Exclusive Patent License to Veloxint CIF, Inc.; Tridelphia, WV

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
November 14, 2023

Issuing agencies

Defense DepartmentArmy Department

Abstract

The Department of the Army hereby gives notice of its intent to grant to Veloxint CIF, Inc.; a company having its principal place of business at 1142 Middle Creek Road, Tridelphia, WV 26059, an exclusive license.

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 218 (Tuesday, November 14, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 218 (Tuesday, November 14, 2023)]
[Notices]
[Page 77996]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-25063]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Intent To Grant Exclusive Patent License to Veloxint 
CIF, Inc.; Tridelphia, WV

AGENCY: Department of the Army, DoD.

ACTION: Notice of intent.

-----------------------------------------------------------------------

SUMMARY: The Department of the Army hereby gives notice of its intent 
to grant to Veloxint CIF, Inc.; a company having its principal place of 
business at 1142 Middle Creek Road, Tridelphia, WV 26059, an exclusive 
license.

DATES: Written objections must be filed not later than 15 days 
following publication of this announcement.

ADDRESSES: Send written objections to U.S. Army Combat Capabilities 
Development Command Army Research Laboratory, Partnerships Support 
Office, FCDD-RLB-SS/Jason Craley, Building 4402, 6468 Integrity Ct., 
Aberdeen Proving Ground, MD 21005-5425 or email to <a href="/cdn-cgi/l/email-protection#dd928f899c9dbcafb1f3bcafb0a4f3b0b4b1"><span class="__cf_email__" data-cfemail="b9f6ebedf8f9d8cbd597d8cbd4c097d4d0d5">[email&#160;protected]</span></a>.

FOR FURTHER INFORMATION CONTACT: Jason Craley, (410) 306-1275, email: 
<a href="/cdn-cgi/l/email-protection#034c5157424362716f2d62716e7a2d6e6a6f"><span class="__cf_email__" data-cfemail="e4abb6b0a5a4859688ca8596899dca898d88">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: The Department of the Army plans to grant an 
exclusive license to Veloxint CIF, Inc. in all fields of use pertaining 
to the following;

--``Nano-Structured Alloy Material and Method of Synthesizing'', ARL 
21-06, US Patent Application No. 17/700,653, Filing Date: 03/22/2022, 
U.S. Publication No. 2023/0302531A1, Publication Date: 09/28/2023, PCT 
Application No. PCT/US23/31342, Filing Date: 08/29/2023.
--``Oxidation and Corrosion Resistant Nanostructured Copper-Based 
Metallic Systems'', ARL 22-18, US Patent Application No. 18/127,398, 
Filing Date: 03/28/2023, PCT Application No. PCT/US23/32206, Filing 
Date: 09/07/2023.

    The prospective exclusive license may be granted unless within 
fifteen (15) days from the date of this published notice, the U.S. Army 
Combat Capabilities Development Command Army Research Laboratory 
receives written objections including evidence and argument that 
establish that the grant of the license would not be consistent with 
the requirements of 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). 
Competing applications completed and received by the U.S. Army Combat 
Capabilities Development Command Army Research Laboratory within 
fifteen (15) days from the date of this published notice will also be 
treated as objections to the grant of the contemplated exclusive 
license.
    Objections submitted in response to this notice will not be made 
available to the public for inspection and, to the extent permitted by 
law, will not be released under the Freedom of Information Act, 5 
U.S.C. 552.

James W. Satterwhite Jr.,
Army Federal Register Liaison Officer.
[FR Doc. 2023-25063 Filed 11-13-23; 8:45 am]
BILLING CODE 3711-02-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on November 14, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.